%0 Journal Article %1 Kruger.2005b %A Krüger, Stefan %A Silber, Ann-Sophie %A Engel, Christoph %A Görgens, Heike %A Mangold, Elisabeth %A Pagenstecher, Constanze %A Holinski-Feder, Elke %A von Knebel Doeberitz, Magnus, %A Moeslein, Gabriela %A Dietmaier, Wolfgang %A Stemmler, Susanne %A Friedl, Waltraut %A Rüschoff, Josef %A Schackert, Hans K. %D 2005 %J The Lancet. Oncology %K IMISE-Publikationen %N 8 %P 566–572 %T Arg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary non-polyposis colorectal cancer: a case-control study %V 6 %X BACKGROUND RNASEL is thought to be a susceptibility gene for hereditary prostate cancer and encodes the endoribonuclease RNase L, which has a role in apoptosis and is a candidate tumour-suppressor protein. A common sequence variation in RNASEL, Arg462Gln, has been associated with hereditary and sporadic prostate cancer, and the Gln variant has about three-fold reduced RNase activity in vitro. In view of the association between the age of onset of hereditary non-polyposis colorectal cancer and functionally different variants of P53, which play a key part in the apoptotic pathway, we aimed to assess whether the Arg462Gln variation of RNASEL affects the age of onset of hereditary non-polyposis colorectal cancer. METHODS We screened 251 patients with hereditary non-polyposis colorectal cancer who were unrelated, had pathogenic germline mutations in MSH2 (n=141) or MLH1 (n=110), and had colorectal carcinoma as the first tumour, for variation at codon 462 of RNASEL and compared them with 439 healthy controls. FINDINGS The median age of onset was 40 years (range 17-75) for patients with an Arg/Arg genotype at codon 462, 37 years (13-69) for patients with an Arg/Gln genotype, and 34 years (20-49) for those with a Gln/Gln genotype (p=0.0198). Only the RNASEL genotype had a significant effect on age of onset (p=0.0062) in an additive mode of inheritance. Pair-wise comparisons between genotype groups showed that the two homozygous groups (ie, Arg/Arg vs Gln/Gln) differed significantly in age of disease onset (mean age difference 4.8 years SD 1.7, p=0.0044). INTERPRETATION A sequence variation in the prostate-cancer-susceptibility gene RNASEL has a role in a different, unassociated malignant disease. Genotypes at RNASEL codon 462 are associated with age of onset of hereditary non-polyposis colorectal cancer in a dose-dependent way, and might have a role in preventive strategies for this disease.

@article{Kruger.2005b, abstract = {BACKGROUND RNASEL is thought to be a susceptibility gene for hereditary prostate cancer and encodes the endoribonuclease RNase L, which has a role in apoptosis and is a candidate tumour-suppressor protein. A common sequence variation in RNASEL, Arg462Gln, has been associated with hereditary and sporadic prostate cancer, and the Gln variant has about three-fold reduced RNase activity in vitro. In view of the association between the age of onset of hereditary non-polyposis colorectal cancer and functionally different variants of P53, which play a key part in the apoptotic pathway, we aimed to assess whether the Arg462Gln variation of RNASEL affects the age of onset of hereditary non-polyposis colorectal cancer. METHODS We screened 251 patients with hereditary non-polyposis colorectal cancer who were unrelated, had pathogenic germline mutations in MSH2 (n=141) or MLH1 (n=110), and had colorectal carcinoma as the first tumour, for variation at codon 462 of RNASEL and compared them with 439 healthy controls. FINDINGS The median age of onset was 40 years (range 17-75) for patients with an Arg/Arg genotype at codon 462, 37 years (13-69) for patients with an Arg/Gln genotype, and 34 years (20-49) for those with a Gln/Gln genotype (p=0.0198). Only the RNASEL genotype had a significant effect on age of onset (p=0.0062) in an additive mode of inheritance. Pair-wise comparisons between genotype groups showed that the two homozygous groups (ie, Arg/Arg vs Gln/Gln) differed significantly in age of disease onset (mean age difference 4.8 years [SD 1.7], p=0.0044). INTERPRETATION A sequence variation in the prostate-cancer-susceptibility gene RNASEL has a role in a different, unassociated malignant disease. Genotypes at RNASEL codon 462 are associated with age of onset of hereditary non-polyposis colorectal cancer in a dose-dependent way, and might have a role in preventive strategies for this disease.}, added-at = {2014-10-15T15:04:08.000+0200}, author = {Krüger, Stefan and Silber, Ann-Sophie and Engel, Christoph and Görgens, Heike and Mangold, Elisabeth and Pagenstecher, Constanze and Holinski-Feder, Elke and {von Knebel Doeberitz, Magnus} and Moeslein, Gabriela and Dietmaier, Wolfgang and Stemmler, Susanne and Friedl, Waltraut and Rüschoff, Josef and Schackert, Hans K.}, biburl = {https://www.bibsonomy.org/bibtex/297dcfa75b8c6c4a834fafa56ed370a52/drtester}, interhash = {06f2c060b562f7d137e37a523f09273f}, intrahash = {97dcfa75b8c6c4a834fafa56ed370a52}, journal = {The Lancet. Oncology}, keywords = {IMISE-Publikationen}, number = 8, pages = {566–572}, timestamp = {2014-12-03T00:08:45.000+0100}, title = {Arg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary non-polyposis colorectal cancer: a case-control study}, volume = 6, year = 2005 }